Home/Filings/4/0001091818-22-000142
4//SEC Filing

Ferguson Merle 4

Accession 0001091818-22-000142

CIK 0001310488other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 3:45 PM ET

Size

5.8 KB

Accession

0001091818-22-000142

Insider Transaction Report

Form 4
Period: 2022-09-30
Ferguson Merle
DirectorCEO/President/Treasurer10% Owner
Transactions
  • Gift

    Common Stock

    2022-09-3010,00016,990,000 total(indirect: Shares held in a private company)
Footnotes (4)
  • [F1]Bona fide gift of securities given to a third-party which is not a relative or related business entity. Securities gifted from an indirect entity that the reporting person is an executive officer.
  • [F2]Gift transaction, price not applicable.
  • [F3]15,000,000 share are held directly by the reporting individual, 1,990,000 shares held indirectly in a business entity that the reporting person is an executive officer. Total direct and indirect beneficial ownership is 16,990,000.
  • [F4]The reporting person is an Executive Officer of a private company, Trade Exchange International, Inc. Prior to the 10,000 share gift, Trade Exchange International, Inc. owned 2,000,000 share of the issuer; the current indirect holdings is now 1,990,000.

Issuer

BIOFORCE NANOSCIENCES HOLDINGS, INC.

CIK 0001310488

Entity typeother

Related Parties

1
  • filerCIK 0001749860

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 3:45 PM ET
Size
5.8 KB